Skip Navigation

Editorial Board


University of Bristol, UK



Linda Bauld, PhD

University of Stirling, UK
Tobacco Control Policy

Ivan Berlin, MD, PhD

Pitié-Salpêtrière University Hospital, France
Human Pharmacology and Biomarkers

Adriaan Bruijnzeel, PhD

University of Florida, USA
Preclinical and Basic Science

Richard Edwards, MD, MPH, MB Bchir

University of Otago, New Zealand

Karl Fagerström, PhD

Fagerström Consulting, Sweden
Tobacco Dependence

Renee Goodwin, PhD, MPH

The City University of New York and Columbia University, USA
Psychiatric and Substance Use Epidemiology

Brian Hitsman, PhD

Northwestern University, USA
Human Laboratory Studies

Raymond Niaura, PhD

LEGACY, The Schroeder Institute for Tobacco Research and Policy Studies, USA
Behavioural and Clinical Genetics

Marc L. Steinberg, PhD

Rutgers Robert Wood Johnson Medical School, USA
Behavioral Treatments and Psychiatric Comorbidity

Jennifer Unger, PhD

University of Southern California, USA
Health Disparities

Andrea H. Weinberger, PhD

Yeshiva University, USA
Psychiatric Comorbidity


Nii Addy, PhD

Yale School of Medicine, USA

Karen Ahijevych, PhD

Ohio State University, USA

Rebecca Ashare, PhD

University of Pennsylvania School of Medicine, USA

Angela Attwood, PhD

University of Bristol, UK

Jessica Barrington-Trimis, PhD

University of Southern California, USA

Anil Batra, MD

University of Tübingen, Germany

Darlene Brunzell, PhD

Virginia Commonwealth University, USA

Frank Chaloupka, PhD

University of Illinois at Chicago, USA

Carole Clair, MD, MSc

University of Lausanne, Switzerland

Marie Cornelius, PhD

University of Pittsburgh, USA

Sean P. David, MD, DPhil

Stanford University, USA

Roberta Ferrence, PhD

University of Toronto, Canada

Allison Ford, PhD

University of Stirling, UK

Steven Fu, MD, MSCE
Minneapolis VA Center for Chronic Disease Outcomes Research and University of Minnesota, USA
Lisa Fucito, PhD

Yale University School of Medicine, USA

Stephen E. Gilman, ScD

Harvard School of Public Health, USA

Maciej L. Goniewicz, PhD, PharmD

Roswell Park Cancer Institute, USA

Stephen Hecht, PhD

University of Minnesota, USA

Noboru Hiroi, PhD

Albert Einstein College of Medicine, USA

Melbourne Hovell, PhD, MPH

San Diego State University, USA

Taline Khroyan, PhD

SRI International, USA

Tessa Langley, PhD

University of Nottingham, UK

Bernard Le Foll, MD, PhD

Centre for Addiction and Mental Health and University of Toronto, Canada

Karl Erik Lund, PhD

Norwegian Institute for Alcohol and
Drug Research, Tobacco, Norway

James MacKillop, PhD

University of Georgia, USA

Michael Marks, PhD

University of Colorado Boulder, USA

Yves Martinet, MD, PhD

University of Lorraine, Nancy, France

Joseph McClernon, PhD

Duke University Medical Center, USA

Jennifer McClure, PhD

Group Health Cooperative, USA

Hayden McRobbie, MB, ChB

University of Auckland, New Zealand

Kolawole Okuyemi, MD, MPH

University of Minnesota, USA

Cheryl Oncken, MD, MPH

University of Connecticut, USA

Megan Passey, PhD

University of Sydney, Australia

Jennifer Pearson, PhD

LEGACY, Schroeder Institute for Tobacco Research and Policy Studies, USA

Megan Piper, PhD

University of Wisconsin-Madison, USA

Kathryn Pollak, PhD

Duke University, USA

Lorraine R. Reitzel, PhD

University of Houston, USA

Stephen Rennard, MD

University of Nebraska Medical Center, USA; AstraZeneca, Cambridge, UK

Joy Schmitz, PhD

University of Texas, USA

Peter Selby, MBBS
Centre for Addiction and Mental Health, Canada
Mohammed Shoaib, PhD

University of Newcastle, UK

Kamran Siddiqi, PhD

University of York, UK

Andrew Strasser, PhD

University of Pennsylvania, USA

James Thrasher, PhD

University of South Carolina, USA

Jennifer Tidey, PhD

Brown University, USA

Serena Tonstad, MD, PhD

Ulleval University Hospital, Norway


E. Paul Wileyto, PhD

University of Pennsylvania, USA


Gary E. Swan, PhD

Center for Health Sciences, SRI International, USA